Paper · 65285

In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Chen TR. Exp Cell Res, 1977. Cited by 1,912 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Papers, record 65285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/65285

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.; PubMed
Journal: Exp Cell Res; PubMed
Year: 1977; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/65285/; PubMed
DOI: https://doi.org/10.1016/0014-4827(77)90089-1; PubMed
The journal: https://conductscience.org/library/journal-index/0373226; PubMed
Citations, by iCite: 1,912; iCite
Relative citation ratio, by iCite: 53.4; iCite
Revised in PubMed: 2019-07-07; PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Chen TR	T R

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Benzimidazoles	Major topic
Bisbenzimidazole	Major topic
Cells, Cultured	Major topic
Mycoplasma	Major topic
Cell Line
Methods
Microscopy, Fluorescence
Staining and Labeling

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by468

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,912 citations.

PMID	Title	Journal	Year	In Papers	Source
42,985,171	Effects of St. John's Wort extract on the release of paracrine markers and neurite outgrowth in mouse hippocampal HT-22 neuronal cells co-cultured with SIM-A9 microglia.	Front Pharmacol	2026	https://conductscience.org/library/papers/42985171	PubMed
42,046,907	Expanding the Fish-Brain Invitrome With the Senegalese Sole SsB-1 Cell Line-A Versatile Model for Neurotropic Virus Research.	J Fish Dis	2026	https://conductscience.org/library/papers/42046907	PubMed
40,292,524	Ursodeoxycholic Acid Exhibits Greater Inhibitory Effects on Cancerous HCT116 Colon Cells than on Noncancerous NCM460 Colon Cells.	Nutrients	2025	https://conductscience.org/library/papers/40292524	PubMed
39,594,610	Unlocking Potential: A Comprehensive Overview of Cell Culture Banks and Their Impact on Biomedical Research.	Cells	2024	https://conductscience.org/library/papers/39594610	PubMed
39,562,680	Milk derived extracellular vesicle uptake in human microglia regulates the DNA methylation machinery : Short title: milk-derived extracellular vesicles and the epigenetic machinery.	Sci Rep	2024	https://conductscience.org/library/papers/39562680	PubMed
38,780,857	Application of Novel Gill Cell Line from Lates calcarifer for Recognizing Metals Using Probes.	Biol Trace Elem Res	2025	https://conductscience.org/library/papers/38780857	PubMed
38,745,771	Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells.	Explor Target Antitumor Ther	2024	https://conductscience.org/library/papers/38745771	PubMed
38,398,853	Efficacy of Butyrate to Inhibit Colonic Cancer Cell Growth Is Cell Type-Specific and Apoptosis-Dependent.	Nutrients	2024	https://conductscience.org/library/papers/38398853	PubMed
38,117,953	Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy.	J Med Chem	2024	https://conductscience.org/library/papers/38117953	PubMed
37,216,121	A PCR protocol to establish standards for routine mycoplasma testing that by design detects over ninety percent of all known mycoplasma species.	iScience	2023	https://conductscience.org/library/papers/37216121	PubMed

1 to 10 of 468

See all 468 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/65285

GET https://conductscience.org/api/papers/v1/65285/cited_by?page=2

API reference For AI assistants